Andrew Rees - Apr 17, 2023 Form 4 Insider Report for Crocs, Inc. (CROX)

Signature
/s/Daniel Hart, attorney-in-fact
Stock symbol
CROX
Transactions as of
Apr 17, 2023
Transactions value $
-$2,804,583
Form type
4
Date filed
4/18/2023, 08:14 PM
Previous filing
Mar 6, 2023
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CROX Common Stock Sale -$1.28M -9.16K -7.65% $140.02 111K Apr 17, 2023 By Trust F1, F2, F3
transaction CROX Common Stock Sale -$1.52M -10.8K -9.8% $140.41 99.7K Apr 18, 2023 By Trust F1, F3, F4
holding CROX Common Stock 937K Apr 17, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to a sales plan adopted by the reporting person intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.00 to $140.08, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4.
F3 The reporting person is a trustee of the V&M REES REV. TRUST and exercises voting and investment power for the shares beneficially owned by the trust.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.00 to $140.84, inclusive.